In partnership with

Anna's Daybreak News

_{Just facts, you think for yourself}

Friday, 5:38 AM

May 30, 2025

Good morning news friend! Step into the flow of today’s events and see the future taking shape. 📰🌟

Click here to read the poll results and comments from our previous edition. Over 6,493 people gave their opinion about courts halting Liberation Day tariffs, US China relations and more!

Can’t see all 6 articles in this email? The Gmail app sometimes crops our emails, click here to view full edition.

Israel Approves Gaza Ceasefire Proposal

The U.S. proposed a 60-day ceasefire in Gaza to facilitate humanitarian aid, requiring the release of 28 Israeli hostages (10 live hostages and the bodies of 18 deceased individuals) in exchange for 1,236 Palestinian prisoners.

Israel accepted the proposal, while Hamas is reviewing it.

Prime Minister Netanyahu stated the military campaign will continue until all hostages are freed.

The Israeli military has resumed operations since March 18, resulting in approximately 4,000 deaths in Gaza, which includes civilians and Hamas operatives.

Sources: Reuters, Reuters, AP News, BBC, EuroNews, JapanTimes.

Trump’s Tariff Trials

A federal appeals court granted President Trump a temporary stay on a ruling that could have jeopardized his tariff agenda, maintaining the US tariff rate at 15%.

A prior US trade court decision found Trump exceeded his authority under the International Emergency Economic Powers Act. The appeals court is reviewing the case, with responses due by June 5.

Trump's tariffs could have dropped from nearly 27% to below 6%. Companies have reported over $34 billion in losses due to these tariffs.

Treasury Secretary Bessent noted ongoing U.S.-China trade talks have stalled, suggesting dialogue between Trump and Chinese President Xi Jinping may be necessary.

Sources: Bloomberg, Bloomberg, Reuters, AXIOS.

Jobless Claims Surge and Corporate Profits Lower

U.S. initial jobless claims rose by 14,000 to 240,000, exceeding expectations. Continuing claims increased by 26,000 to 1.919 million, the highest since November 2021.

Corporate profits fell by $118.1 billion in Q1, the largest decline since 2020, with nonfinancial domestic firms seeing a $96.7 billion drop. The economy contracted by 0.2%, influenced by a record trade deficit and revised consumer spending growth of 1.2%.

CEO confidence has dropped, with 83% anticipating a recession in the next 12-18 months. Federal Reserve officials express caution over potential labor market risks amid ongoing uncertainty, while interest rates remain steady at 4.25%-4.50%.

Sources: Reuters, WallStreetJournal, Bloomberg, Bloomberg.

SEC Dismisses Binance Lawsuit

The SEC has dismissed its lawsuit against Binance, the largest cryptocurrency exchange, concluding a case initiated in June 2023.

The SEC accused Binance and founder Changpeng Zhao of inflating trading volumes and violating securities laws. The dismissal is "with prejudice," preventing any refile. Following a $4.3 billion settlement over money laundering charges, Zhao served four months in prison but retained a majority stake.

The SEC is moving towards clearer cryptocurrency regulations, having also dismissed lawsuits against entities like Coinbase. Binance is strengthening financial partnerships, including a $2 billion investment from Emirati fund MGX in a new stablecoin, USD1, signaling a regulatory shift in the industry.

Sources: Reuters, CNBC, Financemagnates, Decrypt.

Enzyme for Biofuel Production

Researchers at CNPEM have discovered the metalloenzyme CelOCE, which enhances cellulose conversion for biofuel production. CelOCE doubles the conversion efficiency, achieving over 80% compared to traditional methods.

This enzyme opens cellulose's crystalline structure, allowing glycoside hydrolases to access it and generates peroxide independently, simplifying industrial applications.

With only two commercial biorefineries in Brazil, CelOCE's discovery could boost biofuel output and sustainability. The enzyme's potential extends to environmental bioremediation, and it has been validated on a pilot scale for immediate industrial use.

Sources: Phys, SciTechDaily.

Breast Cancer Treatment Achieves 100% Survival Rate

A trial at Addenbrooke's Hospital introduced a pre-surgery treatment for inherited breast cancer, achieving a 100% survival rate among 39 patients with BRCA1 and BRCA2 mutations.

The approach combined chemotherapy and the targeted drug olaparib, with a 48-hour interval improving results. Only one patient relapsed after three years, compared to 88% survival in a control group receiving chemotherapy alone.

The trial suggests cost savings, as trial participants required olaparib for 12 weeks instead of the usual 12 months post-surgery. Larger studies will assess the treatment's effectiveness and toxicity.

The trial was funded by Cancer Research UK and AstraZeneca, among others.

Sources: SciTechDaily, Openaccessgovernment, Pmlive.

“The world, saturated with artifice, demands infinitely more calibration to produce a modicum of wisdom than the ancients needed for a gaggle of sages. Dealing with a single modern individual, puffed with self-importance, now requires more energy than managing an entire ancient tribe.”

Did you know we also write in-depth deep dives? They are long, packed with insights, and have received rave reviews. If you’re up for a detailed, action-packed read, check them out:

• Ethanol: Hype, Hope or the future of Fuel?

• AI Chip Cold War

• Consumer Spending Trends

Baked with love,

Anna Eisenberg ❤️